Company name: MediCrops
Description: Producer of plant-based pharmaceutical raw materials intended to extract active ingredients for therapeutical utilization. The company cultivates cannabis under a state-approved cultivation license and strives to market a wide collection of premium recreational cannabis’ products at competitive prices, thus, providing medical practitioners with the raw materials to produce drugs for a variety of treatments.
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million): 4.26
Business status: Startup
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company raised CHF 4.2 million of Series A venture funding from undisclosed investors on September 23, 2019. The funds will be used in equipping the production plant with high-performance technology.
Number of active investors:
Profile last updated: 19-Oct-2019
Last known valuation:
Last known valuation date: